Rocaltrol and Prochlorperazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocaltrol (calcitriol) and Prochlorperazine (prochlorperazine). Common drug interactions include chronic kidney disease among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Rocaltrol and Prochlorperazine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Rocaltrol?

Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,562 Rocaltrol users. Check the latest studies of Rocaltrol.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.



On Jul, 17, 2026

20 people who take Rocaltrol and Prochlorperazine together, and have interactions are studied.

Rocaltrol and Prochlorperazine drug interactions.

What are the common drug interactions of Rocaltrol and Prochlorperazine, by gender? *:

female:

  1. Chronic kidney disease
  2. Death
  3. Depression
  4. Gastrointestinal ulcer
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Renal failure (kidney dysfunction)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pyrexia (fever)
  3. Lethargy (tiredness)
  4. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
  5. Loeffler's syndrome (a condition that causes the lungs to become inflamed with increased no. of eosinophilia in blood)
  6. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  7. Oesophageal fistula (a birth defect, with the trachea connected to the oesophagus)
  8. Pain
  9. Pleural effusion (water on the lungs)
  10. Pneumonia

What are the common drug interactions of Rocaltrol and Prochlorperazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Death
  3. Depression
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Blood urea increased
  2. Cardiogenic shock (inadequate circulation of blood)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Death
  5. Decreased appetite
  6. Dyspnoea (difficult or laboured respiration)
  7. Lethargy (tiredness)
  8. Oesophageal fistula (a birth defect, with the trachea connected to the oesophagus)
  9. Pain
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Pain: 11 people, 55.00%
  2. Back Pain: 9 people, 45.00%
  3. Prostate Cancer: 9 people, 45.00%
  4. Osteoporosis (bones weak and more likely to break): 9 people, 45.00%
  5. Metastases To Bone (cancer spreads to bone): 9 people, 45.00%
  6. Depression: 9 people, 45.00%
  7. Sleep Disorder: 9 people, 45.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  9. Bone Disorder: 1 person, 5.00%
  10. Bone Pain: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rocaltrol and Prochlorperazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rocaltrol and Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rocaltrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocaltrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prochlorperazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol and prochlorperazine (the active ingredients of Rocaltrol and Prochlorperazine, respectively), and Rocaltrol and Prochlorperazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: